Education
About Us
Working with TipRanks
Follow Us
Eurobio-Scientific SA (DE:E8TN)
FRANKFURT:E8TN
E8TN Stock Chart & Stats
Day’s Range― - ―
52-Week Range€13.70 - €26.30
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€252.64M
Enterprise Value€63.39M
Total Cash (Recent Filing)€23.07M
Total Debt (Recent Filing)€34.05M
Price to Earnings (P/E)62.8
Beta-0.50
Next Earnings
Oct 14, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding10,248,871
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)1.21
Price to Sales (P/S)0.00
P/FCF Ratio5.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.02%
Mutual Funds
― Other Institutional Investors
99.98% Public Companies and
Individual Investors
E8TN FAQ
What was Eurobio-Scientific SA’s price range in the past 12 months?
Eurobio-Scientific SA lowest stock price was €13.70 and its highest was €26.30 in the past 12 months.
What is Eurobio-Scientific SA’s market cap?
Eurobio-Scientific SA’s market cap is €252.64M.
When is Eurobio-Scientific SA’s upcoming earnings report date?
Eurobio-Scientific SA’s upcoming earnings report date is Oct 14, 2025 which is in 97 days.
How were Eurobio-Scientific SA’s earnings last quarter?
Eurobio-Scientific SA released its earnings results on Apr 28, 2025. The company reported €0 earnings per share for the quarter, the consensus estimate of N/A by €0.
Is Eurobio-Scientific SA overvalued?
According to Wall Street analysts Eurobio-Scientific SA’s price is currently Overvalued.
Does Eurobio-Scientific SA pay dividends?
Eurobio-Scientific SA does not currently pay dividends.
What is Eurobio-Scientific SA’s EPS estimate?
Eurobio-Scientific SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eurobio-Scientific SA have?
Eurobio-Scientific SA has 10,248,871 shares outstanding.
What happened to Eurobio-Scientific SA’s price movement after its last earnings report?
Eurobio-Scientific SA reported an EPS of €0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -0.412%.
Which hedge fund is a major shareholder of Eurobio-Scientific SA?
Currently, no hedge funds are holding shares in DE:E8TN
Company Description
Eurobio-Scientific SA
Eurobio Scientific Société anonyme designs, develops, and commercializes specialty diagnostic products in the areas of transplantation, infectious diseases, life-science, and cancer. The company offers Tetanus Quick Stick, a test that is used in emergency clinics for the determination of the tetanus vaccination status of a patient; and commercializes cell culture media, molecular biology reagents, and proprietary antibodies. Its in-house development products include the BJI InoPlex, a multiplex serological test used for the diagnosis of prosthetic joint infections; EBX-044 PCR test to enable the identification of SARS-CoV-2 variants; and licensed products comprise AlloMap, a gene-expression profiling based blood test for the surveillance of heart-transplant patients. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.
Technical Analysis
Novacyt
―
Diagnostic Medical Systems
―
Ikonisys SA
―
Median Technologies
―
Euroapi SA
―